Mutations in crdiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy

Edwin Kirk, Margaret Sunde, Mauro Da Costa, Scott Rankin, Orit Wolstein, M Castro, Tanya Butler, Changbaig Huyn, Guanglan Guo, Robyn Otway, Joel Mackay, Leigh Waddell, Andrew Cole, Christopher Hayward, Anne Keogh, Peter Macdonald, Lyn Griffiths, Diane Fatkin, Gary Sholler, Aaron ZornMichael Feneley, David Winlaw, Richard Harvey

Research output: Contribution to journalArticleResearchpeer-review

243 Citations (Scopus)

Abstract

The T-box family transcription factor gene TBX20 acts in a conserved regulatory network, guiding heart formation and patterning in diverse species. Mouse Tbx20 is expressed in cardiac progenitor cells, differentiating cardiomyocytes, and developing valvular tissue, and its deletion or RNA interference-mediated knockdown is catastrophic for heart development. TBX20 interacts physically, functionally, and genetically with other cardiac transcription factors, including NKX2-5, GATA4, and TBX5, mutations of which cause congenital heart disease (CHD). Here, we report nonsense (Q195X) and missense (I152M) germline mutations within the T-box DNA-binding domain of human TBX20 that were associated with a family history of CHD and a complex spectrum of developmental anomalies, including defects in septation, chamber growth, and valvulogenesis. Biophysical characterization of wild-type and mutant proteins indicated how the missense mutation disrupts the structure and function of the TBX20 T-box. Dilated cardiomyopathy was a feature of the TBX20 mutant phenotype in humans and mice, suggesting that mutations in developmental transcription factors can provide a sensitized template for adult-onset heart disease. Our findings are the first to link TBX20 mutations to human pathology. They provide insights into how mutation of different genes in an interactive regulatory circuit lead to diverse clinical phenotypes, with implications for diagnosis, genetic screening, and patient follow-up.
Original languageEnglish
Pages (from-to)280 - 291
Number of pages12
JournalAmerican Journal of Human Genetics
Volume81
Issue number2
DOIs
Publication statusPublished - 2007
Externally publishedYes

Cite this